Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-03-19
1978-04-18
Torrence, Dolph H.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260465E, 26050117, 260566AE, 424316, 424327, A61K 3115, A61K 31275, C07C12178, C07C13100
Patent
active
040852253
ABSTRACT:
Novel 4'-trifluoromethylvalerophenone 0-(2-aminoethyl)oximes are found to exhibit a strong anti-depressive activity based on a strong serotone potentiation but with the absence of monoamino/oxidase inhibition and undesirable side effects.
REFERENCES:
patent: 3692835 (1972-09-01), Van Dijk et al.
Claassen Volkert
Welle Hendricus Bernardus Antonius
Spain Norman N.
Torrence Dolph H.
Trifari Frank R.
U.S. Philips Corporation
LandOfFree
Oxime ethers having anti-depressive activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxime ethers having anti-depressive activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime ethers having anti-depressive activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2147571